Does evidence from RCTs suggest: SGLT2 inhibitors could not reduce myocardial infarction and stroke?
Lixin Du(Hunan University of Traditional Chinese Medicine), Jun Xia, Huayu Huang(Longgang Central Hospital), Wende Cheng(Longgang Central Hospital), Lan Peng(Longgang Central Hospital), Zhigang Li(Beijing University of Chinese Medicine)
Cited by 1
Related Papers
Unveiling the future: Advancements in MRI imaging for neurodegenerative disorders
|Ageing Research Reviews|2024|69
Upregulation of microRNA‑206 induces apoptosis of vascular smooth muscle cells and decreases risk of atherosclerosis through modulating FOXP1
|Experimental and Therapeutic Medicine|2017|30
A Survey of Pretraining on Graphs: Taxonomy, Methods, and Applications
|arXiv (Cornell University)|2022|27
Therapeutic Potential of Ginsenoside Rb1-PLGA Nanoparticles for Heart Failure Treatment via the ROS/PPARα/PGC1α Pathway
|Molecules|2023|17
Preparation, characterization and in vivo pharmacokinetic study of ginsenoside Rb1-PLGA nanoparticles
|Scientific Reports|2023|16